281 related articles for article (PubMed ID: 31535207)
1. Association between body size-metabolic phenotype and nonalcoholic steatohepatitis and significant fibrosis.
Kim D; Kim W; Joo SK; Han J; Kim JH; Harrison SA; Younossi ZM; Ahmed A
J Gastroenterol; 2020 Mar; 55(3):330-341. PubMed ID: 31535207
[TBL] [Abstract][Full Text] [Related]
2. Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease.
du Plessis J; van Pelt J; Korf H; Mathieu C; van der Schueren B; Lannoo M; Oyen T; Topal B; Fetter G; Nayler S; van der Merwe T; Windmolders P; Van Gaal L; Verrijken A; Hubens G; Gericke M; Cassiman D; Francque S; Nevens F; van der Merwe S
Gastroenterology; 2015 Sep; 149(3):635-48.e14. PubMed ID: 26028579
[TBL] [Abstract][Full Text] [Related]
3. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
[TBL] [Abstract][Full Text] [Related]
4. Predictors of nonalcoholic steatohepatitis and significant fibrosis in non-obese nonalcoholic fatty liver disease.
Kim D; Kim W; Joo SK; Kim JH; Harrison SA; Younossi ZM; Ahmed A
Liver Int; 2019 Feb; 39(2):332-341. PubMed ID: 30298568
[TBL] [Abstract][Full Text] [Related]
5. Correlation of adipose tissue with liver histology in Asian Indian patients with nonalcoholic fatty liver disease (NAFLD).
Choudhary NS; Duseja A; Kalra N; Das A; Dhiman RK; Chawla YK
Ann Hepatol; 2012; 11(4):478-86. PubMed ID: 22700629
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of non-alcoholic steatohepatitis among lean patients in Japan: Not uncommon and not always benign.
Tobari M; Hashimoto E; Taniai M; Ikarashi Y; Kodama K; Kogiso T; Tokushige K; Takayoshi N; Hashimoto N
J Gastroenterol Hepatol; 2019 Aug; 34(8):1404-1410. PubMed ID: 30590868
[TBL] [Abstract][Full Text] [Related]
7. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A
Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
[TBL] [Abstract][Full Text] [Related]
8. Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults.
Neeland IJ; Ayers CR; Rohatgi AK; Turer AT; Berry JD; Das SR; Vega GL; Khera A; McGuire DK; Grundy SM; de Lemos JA
Obesity (Silver Spring); 2013 Sep; 21(9):E439-47. PubMed ID: 23687099
[TBL] [Abstract][Full Text] [Related]
9. Metabolically healthy and unhealthy obesity: differential effects on myocardial function according to metabolic syndrome, rather than obesity.
Dobson R; Burgess MI; Sprung VS; Irwin A; Hamer M; Jones J; Daousi C; Adams V; Kemp GJ; Shojaee-Moradie F; Umpleby M; Cuthbertson DJ
Int J Obes (Lond); 2016 Jan; 40(1):153-61. PubMed ID: 26271188
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of Nonalcoholic Steatohepatitis-Associated Cirrhosis in the United States: An Analysis of National Health and Nutrition Examination Survey Data.
Kabbany MN; Conjeevaram Selvakumar PK; Watt K; Lopez R; Akras Z; Zein N; Carey W; Alkhouri N
Am J Gastroenterol; 2017 Apr; 112(4):581-587. PubMed ID: 28195177
[TBL] [Abstract][Full Text] [Related]
11. Association Between Indices of Body Composition and Metabolically Unhealthy Phenotype in China: A Cross-Sectional Study.
Lv F; Cai X; Li Y; Fu Z; Zhang X; Zhou X; Han X; Ji L
Front Endocrinol (Lausanne); 2022; 13():891327. PubMed ID: 35615717
[TBL] [Abstract][Full Text] [Related]
12. Visceral Obesity Predicts Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Yu SJ; Kim W; Kim D; Yoon JH; Lee K; Kim JH; Cho EJ; Lee JH; Kim HY; Kim YJ; Kim CY
Medicine (Baltimore); 2015 Dec; 94(48):e2159. PubMed ID: 26632897
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic Fatty Liver Disease Severity Is Related to Plasma Pro-Oxidative Biomarkers Rather Than Liver Tissue-Measured Nitrogen Metabolism Biomarkers in Population with Obesity and Metabolic Syndrome.
Suárez-Cuenca JA; Domínguez-Pérez GA; Hernández-Muñóz RE; Hernández-Patricio A; Vera-Gómez E; Gutiérrez-Buendía JA; Salamanca-García M; Montoya-Ramírez J; Gaytán-Fuentes OF; Aranda-Rodríguez C; Rojas-Noverón AR; García S; Mondragón-Terán P
Metab Syndr Relat Disord; 2023 Mar; 21(2):115-121. PubMed ID: 36787445
[No Abstract] [Full Text] [Related]
14. Different effects of low muscle mass on the risk of non-alcoholic fatty liver disease and hepatic fibrosis in a prospective cohort.
Choe HJ; Lee H; Lee D; Kwak SH; Koo BK
J Cachexia Sarcopenia Muscle; 2023 Feb; 14(1):260-269. PubMed ID: 36403577
[TBL] [Abstract][Full Text] [Related]
15. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
16. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
[TBL] [Abstract][Full Text] [Related]
17. Visceral and subcutaneous abdominal fat is associated with non-alcoholic fatty liver disease while augmenting Metabolic Syndrome's effect on non-alcoholic fatty liver disease: A cross-sectional study of NHANES 2017-2018.
Elguezabal Rodelo RG; Porchia LM; Torres-Rasgado E; López-Bayghen E; Gonzalez-Mejia ME
PLoS One; 2024; 19(2):e0298662. PubMed ID: 38394065
[TBL] [Abstract][Full Text] [Related]
18. The impact of body mass index on clinicopathological features of nonalcoholic fatty liver disease in Taiwan.
Lin CL; Tai CM; Huang JF; Liu CJ; Chen HF; Cheng PN; Chen CY; Peng CY; Wang CC; Weng SH; Tseng TC; Kao JH
J Gastroenterol Hepatol; 2022 Oct; 37(10):1901-1910. PubMed ID: 35790343
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity.
Barchetta I; Enhörning S; Cimini FA; Capoccia D; Chiappetta C; Di Cristofano C; Silecchia G; Leonetti F; Melander O; Cavallo MG
BMC Med; 2019 Apr; 17(1):85. PubMed ID: 31035998
[TBL] [Abstract][Full Text] [Related]
20. Non-obese histologically confirmed NASH patients with abnormal liver biochemistry have more advanced fibrosis.
Wang Q; You H; Ou X; Zhao X; Sun Y; Wang M; Wang P; Wang Y; Duan W; Wang X; Wu S; Kong Y; Saxena R; Gouw ASH; Jia J
Hepatol Int; 2019 Nov; 13(6):766-776. PubMed ID: 31559605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
